2.4.2. Criteria for discontinuation of protocol treatment.
ADVERSE EVENTS, EVENTS
The principal investigator or sub-investigator will discontinue the intervention if any of the following events occur.Participants request to discontinue the study drug intake.Participants are unable to continue the therapeutic intervention due to adverse events and illness.Unexpected administration of prohibited or restricted concomitant drugs to the participants.Participants are found to have conflict with the eligibility criteria after the start of the protocol treatment.Participants or their partners withdraw consent.The principal investigator or sub-investigator determines that the subjects are unable to continue receiving the study drug.